Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats.
about
Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundanceBlood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade.Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockadeTumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells.Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways.Association between circulating specific leukocyte types and blood pressure: the atherosclerosis risk in communities (ARIC) studyCaptopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.Salt-induced renal injury in SHRs is mediated by AT1 receptor activation.Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease.Intratubular renin-angiotensin system in hypertensionUrinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats.Rho-kinase/nuclear factor-κβ/angiotensinogen axis in angiotensin II-induced renal injury.Urinary angiotensinogen as a potential biomarker of diabetic nephropathy.Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease.Angiopoietin-1 gene therapy attenuates hypertension and target organ damage in nitric oxide synthase inhibited spontaneously hypertensive rats.Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study.Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation.Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys.Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice.Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusionsPlasma Soluble (Pro)renin Receptor Reflects Renal DamageLiver angiotensinogen is the primary source of renal angiotensin II.Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trialYoung Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseasesIncreased urinary excretion of angiotensinogen is associated with risk of chronic kidney diseaseNovel sandwich ELISA for human angiotensinogenCrucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injuryUrinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetesCleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the spontaneously hypertensive rat.Fetal programming of hypertension.Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidneyPharmacological management of renal fibrotic disease.Important aspects of urine sampling for angiotensinogen measurement: time and preservation conditions in healthy individuals
P2860
Q28571965-B61AB031-A0A9-499D-A646-123EA91CEE24Q33677156-92A7C834-D335-4167-9CFB-84099EFE44A9Q33714897-99F66982-7A55-4A45-A626-E57D76E65F79Q33716378-627C5FEE-54C3-44FB-8E3E-A4458C94CC2AQ33887622-D73284AB-9519-43DB-8C60-1DDF6C0E9E31Q34203622-B7DB23AD-01FD-4DE6-B7EE-9A7401958D62Q34211709-D0235EAD-3E96-4949-91DD-C388895468FCQ34283151-9665526D-D490-4BBE-86F7-382DDFE8187FQ34460012-4A600E74-AB86-4B93-B715-BD0197111C75Q34642815-C49A4F14-BD9F-4B78-82D8-E6E155ED1F68Q34647857-B037BF4B-FD8D-4C00-BB52-67ED8859853AQ34715015-38C8594F-CDEF-43B0-96D8-5D1E53337DFCQ34777649-41F8633B-AFCA-46F3-A535-BC070DEAECEBQ35025450-7CBD340A-64B9-4ABE-9582-28284DFF6909Q35161497-1965721B-A8CA-4EEF-9271-CABF757445A8Q35176118-2A63403D-8921-4168-9C48-5DF77EB4C406Q35227691-BAA7E1C9-8CEC-497C-9F99-EDB238589C39Q35245800-056AB1F2-A320-4BDC-91C2-F8501A04E8C0Q35566707-51292146-2DA2-4548-8022-1363BD2A146CQ35663915-3B9DB8DF-C116-48AC-8AD3-6FAD9AD26677Q35745326-6E7D3EAA-9212-4868-B66C-32F1C37B310CQ35842921-778DC9C3-8768-4FAF-B166-CF81C930042CQ35913007-98BC89D6-0983-4D3E-961A-B874AC30D122Q35934092-A8856651-E35B-4636-B44C-3E4E21D12C5CQ35995685-AAC12298-5EAC-4489-9725-3CF5A54185ACQ36023483-5869398B-7313-466A-A9B9-891492BD111AQ36026798-4C432C77-5C05-491F-BCDE-F3BCD6FE79CAQ36030615-5CBAA39C-DA63-4F4E-AA93-EBD950D7744BQ36050931-B6DFF6A2-B4F9-4C75-92D9-6EBCF34F03C4Q36079520-2D677372-2B81-4856-94EF-27225CB15C1BQ36116868-70CBCFD9-AFC1-492B-AF08-BEF6BDFB2436Q36129853-529862DA-7324-4450-99D3-D21071A6ED1BQ36168729-96CFA153-4FD8-47FC-AFE1-02395C929A19Q36168835-2DA84F6A-77E6-4CF2-A875-13B6CAF59AFCQ36236725-DDEC157F-5DFD-4417-B16B-A0BF27B39AF6Q36274816-F6A23002-3E34-4DC9-B930-A02B183A2AE6Q36341270-F2E0141A-ABBA-44FE-984F-507ED42A7890Q36405827-3E00C598-77EA-449D-8A86-3575D2090A23Q36407348-C11418B1-9FA3-4B34-9CF3-5475D497C912Q36421164-8FDFD760-24A5-43A0-AC1D-FE71E5DD1CA2
P2860
Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.
@ast
Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.
@en
type
label
Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.
@ast
Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.
@en
prefLabel
Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.
@ast
Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.
@en
P2093
P2860
P356
P1476
Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.
@en
P2093
Akira Nishiyama
Hiroyuki Kobori
Yuki Suzaki
Yuri Ozawa
P2860
P304
P356
10.1681/ASN.2004080676
P577
2005-05-11T00:00:00Z